MAP4K3 and non-small cell lung carcinoma: Down-regulated hsa-let-7c was significantly associated with metastasis and poor survival of patients, and hsa-let-7c inhibits cancer metastasis by degrading ITGB3 and MAP4K3 in non-small cell lung cancer [30].